Skip to content

Moderna, Inc.

MRNA

CIK 0001682852

← back to feed
Revenue (TTM)
$1.66B
−39.9% YoY Q1 Apr 2026
Net Income (TTM)
−$3.34B
+20.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$8.56
+21.8% YoY Q1 Apr 2026
Gross Margin
17.2%
Q1 Apr 2026
Operating Margin
-217.8%
Q1 Apr 2026
Net Margin
-201.8%
Q1 Apr 2026
Free Cash Flow (TTM)
−$4.37B
Q1 Apr 2026
Cash
$1.91B
Q1 Apr 2026
Total Debt
$590M
Q1 Apr 2026
Shares Outstanding
396.79M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings